245 related articles for article (PubMed ID: 26272151)
1. Analysis of Sinusoidal Drug Uptake Transporter Activities in Primary Human Hepatocytes.
Le Vée M; Jouan E; Denizot C; Parmentier Y; Fardel O
Methods Mol Biol; 2015; 1250():287-302. PubMed ID: 26272151
[TBL] [Abstract][Full Text] [Related]
2. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.
Le Vee M; Lecureur V; Stieger B; Fardel O
Drug Metab Dispos; 2009 Mar; 37(3):685-93. PubMed ID: 19074973
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes.
Schaefer M; Morinaga G; Matsui A; Schänzle G; Bischoff D; Süssmuth RD
Drug Metab Dispos; 2018 Feb; 46(2):166-177. PubMed ID: 29212823
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: "SLC-Phenotyping" Using Primary Human Hepatocytes.
Bi YA; Costales C; Mathialagan S; West M; Eatemadpour S; Lazzaro S; Tylaska L; Scialis R; Zhang H; Umland J; Kimoto E; Tess DA; Feng B; Tremaine LM; Varma MVS; Rodrigues AD
J Pharmacol Exp Ther; 2019 Jul; 370(1):72-83. PubMed ID: 30975793
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Proteomic Quantification Approaches for Hepatic Drug Transporters: Multiplexed Global Quantitation Correlates with Targeted Proteomic Quantitation.
Vildhede A; Nguyen C; Erickson BK; Kunz RC; Jones R; Kimoto E; Bourbonais F; Rodrigues AD; Varma MVS
Drug Metab Dispos; 2018 May; 46(5):692-696. PubMed ID: 29439128
[TBL] [Abstract][Full Text] [Related]
6. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
[TBL] [Abstract][Full Text] [Related]
7. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes.
Le Vee M; Lecureur V; Moreau A; Stieger B; Fardel O
Drug Metab Dispos; 2009 Nov; 37(11):2228-35. PubMed ID: 19661216
[TBL] [Abstract][Full Text] [Related]
9. OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP.
Zhang Y; Ruggiero M; Hagenbuch B
Drug Metab Dispos; 2020 Aug; 48(8):622-630. PubMed ID: 32482756
[TBL] [Abstract][Full Text] [Related]
10. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract.
Le Vee M; Jouan E; Stieger B; Lecureur V; Fardel O
PLoS One; 2015; 10(3):e0121232. PubMed ID: 25803276
[TBL] [Abstract][Full Text] [Related]
12. Interaction of human organic anion transporter 2 (OAT2) and sodium taurocholate cotransporting polypeptide (NTCP) with antineoplastic drugs.
Marada VV; Flörl S; Kühne A; Müller J; Burckhardt G; Hagos Y
Pharmacol Res; 2015 Jan; 91():78-87. PubMed ID: 25481222
[TBL] [Abstract][Full Text] [Related]
13. Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells.
Le Vee M; Noel G; Jouan E; Stieger B; Fardel O
Toxicol In Vitro; 2013 Sep; 27(6):1979-86. PubMed ID: 23850984
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent activity of the uptake transporters Ntcp and Oatp1b2 in male rat hepatocytes: from birth till adulthood.
Fattah S; Augustijns P; Annaert P
Drug Metab Dispos; 2015 Jan; 43(1):1-8. PubMed ID: 25305012
[TBL] [Abstract][Full Text] [Related]
15. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7).
Mathialagan S; Bi YA; Costales C; Kalgutkar AS; Rodrigues AD; Varma MVS
Biochem Pharmacol; 2020 Apr; 174():113829. PubMed ID: 32001236
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes.
Jigorel E; Le Vee M; Boursier-Neyret C; Bertrand M; Fardel O
Drug Metab Dispos; 2005 Oct; 33(10):1418-22. PubMed ID: 16014767
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.
Le Vee M; Gripon P; Stieger B; Fardel O
Drug Metab Dispos; 2008 Feb; 36(2):217-22. PubMed ID: 17991769
[TBL] [Abstract][Full Text] [Related]
19. Functional expression and regulation of drug transporters in monolayer- and sandwich-cultured mouse hepatocytes.
Noel G; Le Vee M; Moreau A; Stieger B; Parmentier Y; Fardel O
Eur J Pharm Sci; 2013 Apr; 49(1):39-50. PubMed ID: 23396053
[TBL] [Abstract][Full Text] [Related]
20. Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans.
Liao M; Zhu Q; Zhu A; Gemski C; Ma B; Guan E; Li AP; Xiao G; Xia CQ
Xenobiotica; 2019 Jul; 49(7):852-862. PubMed ID: 30132394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
